Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing tafenoquine for Plasmodium vivax treatment in adults; study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria, Plasmodium Vivax | Phase 2 | Status: TERMINATED | Results posted: 2018-01-25